Published online Aug 28, 2023. doi: 10.3748/wjg.v29.i32.4851
Peer-review started: May 28, 2023
First decision: July 8, 2023
Revised: July 18, 2023
Accepted: August 2, 2023
Article in press: August 2, 2023
Published online: August 28, 2023
Processing time: 88 Days and 16 Hours
Marginal zone lymphomas rank as the third most prevalent form of non-Hodgkin B-cell lymphoma, trailing behind diffuse large B-cell lymphoma and follicular lymphoma. Gastric mucosa-associated lymphoid tissue lymphoma (GML) is a low-grade B-cell neoplasia frequently correlated with Helicobacter pylori (H. pylori)-induced chronic gastritis. On the other hand, a specific subset of individuals diagnosed with GML does not exhibit H. pylori infection. In contrast to its H. pylori-positive counterpart, it was previously believed that H. pylori-negative GML was less likely to respond to antimicrobial therapy. Despite this, surprisingly, in-creasing evidence supports that a considerable proportion of patients with H. pylori-negative GML show complete histopathological remission after bacterial eradication therapy. Nonetheless, the precise mechanisms underlying this treatment responsiveness are not yet fully comprehended. In recent years, there has been growing interest in investigating the role of non-H. pylori gastric helicobacters (NHPHs) in the pathogenesis of H. pylori-negative GML. However, additional research is required to establish the causal relationship between NHPHs and GML. In this minireview, we examined the current understanding and proposed prospects on the involvement of NHPHs in H. pylori-negative GML, as well as their potential response to bacterial eradication therapy.
Core Tip: Gastric mucosa-associated lymphoid tissue lymphoma (GML) is a type of non-hodgkin lymphoma that arises in the stomach. It has been well-established that Helicobacter pylori (H. pylori) infection plays a crucial role in the development of GML. However, a subset of patients diagnosed with GML are negative for H. pylori. In recent years, there has been growing interest in investigating the role of non-H. pylori gastric helicobacters (NHPHs) in the pathogenesis of H. pylori-negative GML. This minireview aims to explore the current understanding of the involvement of NHPHs in the development of GML and its potential responsiveness to bacterial eradication therapy.